Korea United Pharm. Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
1
Ending by 2030
Feb 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 25, 2027The maintenance fee for Method for preparing organic solvent-free lyophilized cyclophosphamide (US 11,707,434) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 1 fee due Apr 24, 2027The maintenance fee for Pharmaceutical composition comprising THA as active ingredient for treating breast cancer (US 11,793,772) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
- 1 fee due May 10, 2027The maintenance fee for Slow-release cilostazol tablet having an improved elution rate and minimal side effects (US 9,180,198) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
- 1 fee due Aug 13, 2027The maintenance fee for Core tablet composite preparation comprising mosapride and rabeprazole (US 11,896,718) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
- 1 fee due Nov 5, 2027The maintenance fee for Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis (US 10,639,320) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,180,198 | Slow-release cilostazol tablet having an improved elution rate and minimal side effects In force · USPTO record | In force | USPTO record | |
| US D791,931 | Medicine inhaler In force · USPTO record | In force | USPTO record | |
| US 9,962,390 | Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration In force · USPTO record | In force | USPTO record | |
| US 10,639,320 | Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis In force · USPTO record | In force | USPTO record | |
| US 11,033,505 | Oral complex preparation comprising fat-soluble drug and solid preparation coated with oil-proof material In force · USPTO record | In force | USPTO record | |
| US 11,000,481 | Composite preparation of mosapride and rabeprazole In force · USPTO record | In force | USPTO record | |
| US 11,793,772 | Pharmaceutical composition comprising THA as active ingredient for treating breast cancer In force · USPTO record | In force | USPTO record | |
| US 11,896,718 | Core tablet composite preparation comprising mosapride and rabeprazole In force · USPTO record | In force | USPTO record | |
| US 11,484,511 | Pharmaceutical composition comprising THA as effective ingredient for treatment of prostate cancer In force · USPTO record | In force | USPTO record | |
| US 11,707,434 | Method for preparing organic solvent-free lyophilized cyclophosphamide In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 11: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 3 no status recorded